Marc Monseau

From journalism to digital communications, I've spent my career using different platforms to reach and inform

[Marc Monseau @MDMonseau]

https://t.co/CFTRznQGrH

[The Max Foundation @themaxfndn]

Excited to share that @FiercePharma has recognized our CEO as a Health Equity Honoree 🙏🏾The Fierce 50 showcases 50 companies and individuals driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare. https://t.co/Fcan5wTMQ4

[nference @_nference]

Check out this recent article in the Washington Post about the Mayo Clinic Platform's role in the AI revolution in healthcare. We are honored to collaborate with this organization to help transform healthcare. #data #healthcare #ai #FederatedAI

https://t.co/nyqu8fdcnJ

[Marc Monseau @MDMonseau]

Last chance to apply for the @pharmstars Fall Cohort. Get your applications in today!

[IrmaRaste ✨ InfluenceThroughStorytelling™ @IrmaRaste]

🔊👋 Are you a #DigitalHealth #startup that is looking to engage with key #pharma stakeholders? @PharmStars #accelerator can help!

You should consider applying for the Fall 2023 cohort if you are working on novel #DrugDelivery platforms and innovative solutions, such as:

✅ Companion Devices
✅#Adhesives, Implantables & #ClosedLoop Systems
✅ Dynamic Dosing
✅ #Sustainability & #Recycling

⏰🚪The window of opportunity closes on July 10th at midnight ET!
🏃‍♀️ to APPLY: https://t.co/AFq8cZ3nO6

#startups #investors #VCs #venturecapital #acceleratorprogram #DigitalHealth #founders #funders #WomenFounders #entrepreneurs #biotech #biopharma #healthcare #HealthTech #partnerships #education #entrepreneurship #diversefounders #womeninbusiness

[nference @_nference]

We are honored to share that the Journal of Clinical Oncology has selected our research study as Best of JCO Oncology Practice for the 2023 Annual Meeting Edition.

The study, conducted in collaboration with the Mayo Clinic and Janssen Pharmaceuticals, details the characteristics of subcutaneous and intravenous administration of Daratumumab in #MultipleMyeloma patients.

💡 Reduced clinic times were observed with subcutaneous administration of #Daratumumab, indicating that this treatment option results in time savings that may free clinic resources. The study demonstrates that novel methods of electronic health record data extraction can provide insights that may help inform clinic resource optimization.

Read the full paper: https://t.co/XsoljWLYuH

@MayoClinic
@JanssenGlobal
@ASCO
#EHR #AI #NLP #FederatedLearning #Oncology #RWE #ASCO23

[PharmStars @PharmStars]

Listen to Spring'23 cohort #startup graduates @MyLocalInfusion's Tina Liu, @MiMarkdx's @RigauMarina & @nalagenetics' Levi Sani share their surprises & favorite parts of the @PharmStars #pharma-focused #accelerator. Apply today: https://t.co/EuhhOBxWrH
#DigitalHealth

[Marc Monseau @MDMonseau]

Congrats to Chris and all the Spring 20023 graduates. A healthcare #startup interested in partnering with life sciences companies? See if you qualify for the @PharmStars Spring Cohort

[PharmStars @PharmStars]

Hear what @TwillHealth's Chief #Strategy Officer, @chriswasden's, favorite part of the @PharmStars #accelerator was & how the mentoring helped a mature #digitalhealth #startup like Twill. Congrats 👏Chris & all the Spring 2023 graduates! Apply now https://t.co/C2W7N1uSFw

[PharmStars @PharmStars]

Hear what @TwillHealth's Chief #Strategy Officer, @chriswasden's, favorite part of the @PharmStars #accelerator was & how the mentoring helped a mature #digitalhealth #startup like Twill. Congrats 👏Chris & all the Spring 2023 graduates! Apply now https://t.co/C2W7N1uSFw

[IrmaRaste ✨ InfluenceThroughStorytelling™ @IrmaRaste]

🙌 Thanks to @PharmStars, there are 47+ #startups that are now fully equipped to present their #innovations to big #pharma / #biotech companies, engage in fruitful partnerships & benefit #patients as a result!

🔔 If you’re a #DigitalHealth #startup working on a solution that is transforming the #patient-drug interface & interested in being part of the Fall 2023 cohort, ➡ listen up!

⌛ PharmStars is accepting applications around the theme "Digital Innovations in Therapeutic Delivery: From Supply Chain to the Patient Interface"

This is a broad theme which includes:
💊 #NovelDrugDelivery or #DrugAdministration 
Platforms
🩺 #TreatmentManagement & Persistence Solutions
💻 #PatientEducation & #HealthLiteracy Initiatives
🔗#SupplyChainManagement or #Sustainability 
Applications
& more
📣 Do you know anyone (anywhere in the world) who is working on innovations in these areas? If so, DIRECT THEM HERE:
🧲 https://t.co/TzGsDVg9O5

#MedDevice #MedicationAdherence #MedicationManagement #RemotePatientMonitoring #RPM #HealthTech #Telehealth #Coaching #VR #AR #PatientExperience #PatientPortal #Logistics #Recycling #Inventory #Compliance #CellAndGeneTherapy #biopharma @NaomiFried

[Marc Monseau @MDMonseau]

A great assessment of a terrific program designed to help #startups partner with #Pharmaceutical companies. Check it out @chimoose @healthythinker @JohnNosta @ritters90

[PharmStars @PharmStars]

Hear what @TwillHealth's Chief #Strategy Officer, @chriswasden's, favorite part of the @PharmStars #accelerator was & how the mentoring helped a mature #digitalhealth #startup like Twill. Congrats 👏Chris & all the Spring 2023 graduates! Apply now https://t.co/C2W7N1uSFw

[Marc Monseau @MDMonseau]

@PharmStars @manta_cares @LindquistPDX After working with the latest @PharmStars cohort, I can attest to the value this program. Hear more from one of the latest graduates:

[PharmStars @PharmStars]

Hear from @manta_cares' @LindquistPDX on how their #digitalhealth #startups benefited from 1:1 meetings w @PharmStars #pharma members as part of the #accelerator program.👏 Congrats to all the @PharmStars Spring 2023 graduates! Apply to participate: https://t.co/ZfSxHaYiIl

[NPR @NPR]

Princeton sociologist Matthew Desmond says if the top 1% of Americans paid the taxes they owed, it would raise $175 billion each year.

"That is just about enough to pull everyone out of poverty," the author says. https://t.co/YU9SfgcKdi

[Gary Monk @GaryMonk]

Can VR act as a digital therapeutic?
There are neurological benefits to engaging in an immersive environment where experiences can be controlled and stimuli can be regulated.
https://t.co/YXyGrgHfSm
#DigitalHealth #VR #DTx

[Gary Monk @GaryMonk]

How AI Can Help Diagnose Rare Diseases
New model acts as search engine for large databases of pathology images, has potential to identify rare diseases and therapies
https://t.co/SGPxr5pJMf
#DigitalHealth #RareDisease #AI

[Gary Monk @GaryMonk]

💥7 Medical Conditions Virtual Reality (VR) is Helping to Treat >>

🌄See attached Infographic for a rapidly digestible summary!

Link to full article in collaboration with @SidekickHealth > https://t.co/ODDnBroDki

#DigitalHealth #DTx #VR

[Eric Topol @EricTopol]

Some good news for the BA.5 bivalent booster 👍
Immune response protection vs BQ.1.1 and BA.2.75.2
https://t.co/t08KNiBCKY @SutharLab live virus neutralization assay indicates broadened humoral immunity vs new Omicron subvariants (and neutralization > monovalent original booster)

[Sauli Niinistö @niinisto]

I met this morning with President of Moldova @sandumaiamd. We exchanged views about the war in Ukraine, security in the region and Russia’s partial mobilisation. Finland support’s Moldova’s EU path and reforms.

[Marc Monseau @MDMonseau]

Sibelius’ music caught in steel and sky… #finnishwelcome #fulbrightfinland